It's water-soluble, so your body flushes out what it doesn't use, and there's no established toxic dose for healthy people
Participants receiving retatrutide lost an average of 11.5% and as much as 16.8% of their body weight after 40 weeks, far exceeding the placebo groups 2.6% reduction
If you're exploring daily or every-other-day semaglutide dosing (popular in some communities for managing side effects), GLP3 Planner can model those schedules while Shotsy is designed primarily for standard weekly injection tracking
GLP-1 medicines improve liver health regardless of weight loss, say scientists
There is likely a point of diminishing returns where additional receptor activation produces marginal benefit at disproportionate risk
In pulmonary infections, MRSA strains invade lung tissues, causing severe illness